9 commercial payer policies list J1439. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
9 policies from 6 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Codes labeled “Inferred from policy title” are not listed in the policy document; Backwork attached them because the policy title names the drug.
| Policy | Effective | Status of J1439 |
|---|---|---|
| Injectafer (ferric carboxymaltose) | Not recorded | Prior auth requiredInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Injectafer (ferric carboxymaltose)Effective 03/01/2025 - 08/31/2025 | Oct 1, 2024 | Prior auth requiredInferred from policy title |
| Injectafer (ferric carboxymaltose)Effective 09/01/2025 - 08/31/2026 | Sep 1, 2025 | Prior auth requiredInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
|---|
| Policy | Effective | Status of J1439 |
|---|---|---|
| Intravenous Iron Replacement Therapy (Feraheme, Injectafer, & Monoferric) | Feb 1, 2026 | Covered |
| Intravenous Iron Replacement Therapy (Feraheme, Injectafer, & Monoferric) – Community Plan Medical Benefit Drug Policy | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J1439 |
|---|---|---|
| Ferric Carboxymaltose (Injectafer); CP.PHAR.234 | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J1439 |
|---|---|---|
| Injectafer (ferric carboxymaltose injection) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J1439 |
|---|---|---|
| Intravenous Iron Replacement Therapy (Feraheme, Injectafer, & Monoferric) | Feb 1, 2026 | Covered |
| Policy | Effective | Status of J1439 |
|---|---|---|
| Intravenous Iron Replacement Therapy (Feraheme, Injectafer, & Monoferric) | Feb 1, 2026 | Covered |